Thursday 25 June: 14:00-16:00 CET
Zoomlink follows
Chairs: Annette Baas (UMCU) en Herman Silljé (UMCG)
Introduction session by Annette Baas en Herman Silljé
M. Jansen (UMCU): “BIO FOr CARe; Identifying biomarkers of hypertrophic cardiomyopathy in MYBPC3 founder mutation carriers”
R. Huurman (EMC): “Body size: does it matter for diagnosis in hypertrophic cardiomyopathy?”
L. Dorsch (VUMC): “Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy”
M. Schuldt (VUMC): “Proteomic and functional studies reveal detyrosinated tubulin as treatment target in sarcomere mutation-induced hypertrophic cardiomyopathy”
T. Eijgenraam (UMCG): “A translational model of phospholamban p.Arg14del cardiomyopathy””
J. Pei UMCU): “Integration of multi-omics data to unravel cardiomyopathy pathology”